Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.

@article{Dobrzycki2006IsTW,
  title={Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.},
  author={Sławomir Dobrzycki and Grzegorz Mezyński and Paweł Kralisz and Przemysław Prokopczuk and Konrad S. Nowak and Wacław Kochman and Jerzy Żuk and Hanna Bach{\'o}rzewska-Gajewska and Zdzisław Sawicki and Bogusław Poniatowski and Janusz Korecki and Włodzimierz Jerzy Musiał},
  journal={Kardiologia polska},
  year={2006},
  volume={64 8},
  pages={793-9; discussion 800-1}
}
INTRODUCTION The advantage of primary percutaneous coronary intervention (pPCI) in the management of ST-elevation myocardial infarction (STEMI) over thrombolytic therapy has been demonstrated. However, an optimal medical treatment of STEMI patients admitted to regional hospitals without catheterisation facilities has not yet been established. Delay in initiation of pPCI resulting from transportation to the catheterisation laboratory may diminish the benefits of such therapy in comparison with… CONTINUE READING